Adaptyx’s wearable tracks biochemical signals to provide a more comprehensive view of an individual’s health over time.

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...

Introduction The number of people living with dementia is increasing worldwide. Alzheimer’s disease (AD) is the most common type of dementia. It typically manifests itself initially with cognitive ...

For the first time, two cell culture labs and a biochemistry lab have been created specifically for educational purposes, ...

What if a soft material could move on its own, guided not by electronics or motors, but by the kind of rudimentary chemical ...

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...

As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

Bricker, D. , Alberto, J. , Pecar, Z. , Pecar, D. and Asad, S. (2025) Acute Metabolic and Neurocognitive Adaptations to Short-Term Fasting. Food and Nutrition Sciences, 16, 1489-1501. doi: 10.4236/fns ...

This systematic review and meta-analysis found that while yogurt consumption shows a modest positive association with bone ...

Researchers have developed a miniature 3D human colon model that mimics lifelike functions to enhance precision in cancer ...

Researchers have developed the world’s first flow battery powered by glucose and vitamin B2, mimicking the human body’s ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...